Medicare Enrolled

Dr. Naureen Alim, MD

Allergy & Immunology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
6550 FANNIN ST STE 2421, Houston, TX 77030
2818889870
In practice since 2008 (17 years)
NPI: 1134374184 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alim? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alim

Dr. Naureen Alim is an allergy & immunology specialist in Houston, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Alim performed 3,545 Medicare services across 444 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alim received a total of $283,041 from 46 pharmaceutical and/or device companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 38% volume in TX $283,041 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,545
Medicare services
Top 38% in TX for allergy & immunology
444
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~209 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,700 $18 $43
Office visit, established patient (20-29 min) 449 $64 $300
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 93 $51 $210
Drug injection, under skin or into muscle 92 $11 $77
Administration of chemotherapy into vein, 1 hour or less 84 $106 $600
Office visit, established patient (30-39 min) 76 $90 $438
New patient office visit (45-59 min) 26 $124 $676
New patient office visit (30-44 min) 25 $81 $440
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
81.1% medium
16.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$283,041
Total received (2018-2024)
Avg $40,434/year across 7 years
Top 2% in TX for allergy & immunology
46
Companies
762
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$270,177 (95.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,104 (2.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,760 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$110,921
2023
$98,088
2022
$57,113
2021
$13,542
2020
$773
2019
$1,357
2018
$1,247

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$106,478
AbbVie Inc.
$99,262
AstraZeneca Pharmaceuticals LP
$29,350
Amgen Inc.
$17,066
GENZYME CORPORATION
$14,258
GlaxoSmithKline, LLC.
$10,348
US Oncology Corporate, Inc.
$1,123
UCB, Inc.
$542
Novartis Pharmaceuticals Corporation
$502
PFIZER INC.
$450
Lilly USA, LLC
$441
Janssen Biotech, Inc.
$410
Aurinia Pharma U.S., Inc.
$366
Mallinckrodt Hospital Products Inc.
$293
AbbVie, Inc.
$291
E.R. Squibb & Sons, L.L.C.
$204
Arcutis Biotherapeutics, Inc.
$202
Genentech USA, Inc.
$194
Johnson & Johnson Health Care Systems Inc.
$129
Radius Health, Inc.
$111
Cardinal Health 110 LLC
$100
Mallinckrodt Enterprises LLC
$87
Celgene Corporation
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Alexion Pharmaceuticals, Inc.
$59
Grifols USA, LLC
$57
CSL Behring
$57
ANI Pharmaceuticals, Inc.
$52
Merck Sharp & Dohme LLC
$47
Ultragenyx Pharmaceutical Inc.
$43
Merck Sharp & Dohme Corporation
$43
Mallinckrodt LLC
$40
Organon LLC
$34
Sandoz Inc.
$32
Gilead Sciences, Inc.
$27
MEDAC PHARMA, INC.
$25
Organon Llc
$24
Kyowa Kirin, Inc.
$24
SOBI, INC
$21
Octapharma USA, Inc.
$20
MEDEXUS PHARMA, INC.
$18
Antares Pharma, Inc.
$16
Sobi, Inc
$16
Kiniksa Pharmaceuticals International, plc
$15
Horizon Therapeutics plc
$13
Kiniksa Pharmaceuticals, Ltd.
$12
Top 3 companies account for 83.1% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DIFICID · DUPIXENT · EVENITY · Enbrel · Gamunex-C · HADLIMA · HUMIRA · HYRIMOZ · Haegarda · Humira · INFLECTRA · KEVZARA · KINERET · Kineret · LUPKYNIS · LYRICA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · Prolia · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TEZSPIRE · TREMFYA · Tavneos · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for allergy & immunology in TX.

Equivalent to $7,984 per 100 Medicare services performed
Looking for an allergy & immunology specialist in Houston?
Compare allergy & immunologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
62
Per 100K population
1.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alim is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alim experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Alim performed 2,700 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alim receive payments from pharmaceutical companies?
Yes. Dr. Alim received a total of $283,041 from 46 companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alim's costs compare to other allergy & immunologists in Houston?
Dr. Alim's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →